James Scott, BS, M.Ed., PharmD
Associate Dean, Experiential and Professional Affairs, Professor, Pharmacy Practice and Administration
College of Pharmacy
Join year: May, 2000
University of Florida
University of Florida
University of Florida
Dr. Scott received his Pharm.D. in 1994 from the University of Florida. He completed a 1-year clinical residency in Geriatric Pharmacotherapy in 1995 at the VA Medical Center in Gainesville, Fl. In 1997 he completed a 2-year fellowship in Infectious Diseases Pharmacotherapy at the University of Illinois at Chicago. From July 1997 through April 2000, he was Director of Infection Management at the Clinical Pharmacokinetics Laboratory in Buffalo, NY. He joined WesternU in May of 2000. His research, clinical practice and academic interests are focused in HIV pharmacotherapy and adherence counseling. His research projects have included retrospective analyses evaluating the use and efficacy of HIV therapies, pharmacokinetic studies, and prospective investigator-initiated clinical trials. Dr. Scott is certified by the American Academy of HIV Medicine as a HIV Expert. He currently oversees the experiential portion of the PharmD curriculum at WesternU.
Dr. Scott oversees the Office of Experiential Education and the nearly 45% of our curriculum that occurs in affiliated practice settings. He works to continuously expand and improve the quality of experiential learning through the development new practice sites, by offering training and development programs for adjunct faculty/preceptors, by providing focused resources and support to affiliated teaching sites, and by implementing evaluation and quality assurance measures that will maximize that clinical experience for both students and preceptors.
His current research, clinical practice and academic interests focus in HIV pharmacotherapy and adherence counseling. His recent research projects have included retrospective analyses evaluating the use and efficacy of HIV therapies, pharmacokinetic studies, and prospective investigator initiated clinical trials.
Dr. Scott currently sits on the Boards of Directors for the California Society of Health Systems Pharmacists and the American Academy of HIV Medicine.
Ignoffo R, Chan L, Knapp K, Chan E, Ip E, Bandy J, Besinque K, Colbert J, Duby JJ, Galanto JS, Gloudeman M, Havard P, Lackey G, Lozano E, Scott J, Stewart TL. Efficient and effective precepting of pharmacy students in acute and ambulatory care rotations: A Delphi expert panel study. Am J Health Syst Pharm. Oct 2017, 74(19):1570-78
Hoffman J, Chung E, Hess K, Law AV, Samson BH, Scott JD. Overview of a Co-Curricular Professional Development Program in a College of Pharmacy. Currents in Pharmacy Learning and Teaching, May 2017, 9:398-404..
DenetClaw TH, Young EW, Tiemeier AM, Scott JD, Hartzler ML. Perceptions, Obstacles, and Solutions for Offering Introductory Pharmacy Practice Experiences in the Community Hospital Setting: A Qualitative Study. Currents in Pharmacy Learning and Teaching, 2014, 6:632-8.
Thompson MA, Mugavero MJ, Amico KR, Cargill VA, Chang JW, Gross RA, Orrell C, Altice FL, Bangsberg DR, Bartlett JG, Beckwith CG, Dowshen N, Gordon CM, Horn T, Kumar P, Scott JD, Stirratt MJ, Remien RH, Simoni JM, Nachega J. Guidelines for Improving Entry into and Retention in Care and Antiretroviral Adherence for Persons with HIV: Evidence-Based Recommendations from an International Association of Physicians in AIDS Care Panel. Ann Intern Med, 2012, 156(11):817-33. (PMID: 22393036)
Hata M, Klotz R, Sylvies R, Hess K, Schwartzman E, Scott JD, Law AV. Medication Therapy Management Services Provided by Student Pharmacists. Am J Pharm Ed, 2012, 76(3), Art 51.
Smith KM, Scott DR, Barner JC, DeHart RM, Scott JD, Martin SJ. Interprofessional Education in Six US Colleges of Pharmacy. Am J Pharm Ed, 2009, 73(4) 1-7.
Scott JD, Wolfe PR, Anderson PG, Cohan GR, Scarsella A. Prospective Study of the Safety and Efficacy of Topical Testosterone Gel (AndroGel®) Versus Intramuscular Testosterone for the Treatment of Testosterone Deficiency in HIV-Infected Men. HIV Clin Trials, 2007, 8(6) 412-420 (PMID 18042506).
Scott JD, Wolfe PR, Bolan RK. Serious Renal Impairment Occurs Rarely with the Use of Tenofovir. HIV Clinical Trials, 2006, 7(2), 55-8 (PMID 16798620).